Adam L Boxer Selected Research

Corticobasal Degeneration

10/2020	Four-Repeat Tauopathies: Current Management and Future Treatments.
1/2020	Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.
1/2019	18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.
1/2019	Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers.
1/2018	24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome.
12/2017	Clinicopathological correlations in behavioural variant frontotemporal dementia.
10/2017	18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.
1/2015	Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
8/2012	Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam L Boxer Research Topics

Disease

31	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2005
22	Frontotemporal Dementia (Semantic Dementia) 01/2022 - 10/2007
19	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2022 - 07/2009
19	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 08/2012
15	Dementia (Dementias) 01/2022 - 10/2005
15	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2009
12	Tauopathies 10/2020 - 01/2013
10	Cognitive Dysfunction 01/2022 - 07/2014
9	Corticobasal Degeneration 10/2020 - 08/2012
8	Disease Progression 05/2020 - 07/2010
5	Primary Progressive Aphasia 01/2019 - 09/2013
5	Atrophy 01/2019 - 02/2009
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 08/2012
2	Edema (Dropsy) 01/2020 - 07/2010
2	Motor Neuron Disease (Primary Lateral Sclerosis) 12/2017 - 11/2014
2	Neuroinflammatory Diseases 01/2017 - 03/2013
2	Autoimmune Diseases (Autoimmune Disease) 12/2016 - 09/2013
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Prodromal Symptoms 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Malignant Hypertension 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Headache (Headaches) 01/2019
1	Aspiration Pneumonia 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Contusions 01/2019
1	Memory Disorders (Memory Loss) 01/2018
1	Pick Disease of the Brain (Pick's Disease) 12/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Proteostasis Deficiencies 01/2017
1	Arthritis (Polyarthritis) 12/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2016
1	Amyloid Plaque 07/2015
1	Aphasia (Dysphasia) 11/2014
1	Apraxias (Dyspraxia) 11/2014
1	Parkinsonian Disorders (Parkinsonism) 11/2014
1	Dysarthria (Spastic Dysarthria) 11/2014
1	Epistaxis (Nosebleed) 07/2014
1	Inflammation (Inflammations) 09/2013
1	Protein Deficiency 03/2013
1	Sarcoma (Soft Tissue Sarcoma) 04/2012
1	Primary Progressive Nonfluent Aphasia (Progressive Nonfluent Aphasia) 07/2009

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2014
17	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2014
12	ProgranulinsIBA 01/2021 - 03/2013
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2012
9	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 02/2017
6	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2022 - 04/2012
6	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 08/2012
5	Apolipoproteins E (ApoE)IBA 01/2021 - 02/2009
5	tau Proteins (tau Protein)IBA 10/2020 - 01/2013
4	davunetideIBA 05/2020 - 07/2014
4	Biological ProductsIBA 01/2018 - 10/2005
3	Pharmaceutical PreparationsIBA 03/2013 - 01/2013
2	Amyloid beta-PeptidesIBA 01/2022 - 07/2010
2	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2020
2	Levetiracetam (Keppra)FDA LinkGeneric 11/2021 - 01/2020
2	gosuranemabIBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 01/2019
2	FluorineIBA 01/2021 - 01/2020
2	LigandsIBA 01/2019 - 07/2017
2	Riluzole FDA LinkGeneric 01/2018 - 11/2014
2	Dopamine (Intropin)FDA LinkGeneric 07/2017 - 11/2014
2	Apolipoprotein E4IBA 01/2017 - 02/2009
2	Memantine (Namenda)FDA Link 02/2013 - 07/2009
1	TESIBA 01/2022
1	GranulinsIBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	Threonine (L-Threonine)FDA Link 01/2021
1	Protein Isoforms (Isoforms)IBA 10/2020
1	salicylsalicylic acid (salsalate)IBA 05/2020
1	Protein AggregatesIBA 01/2020
1	aducanumabIBA 01/2020
1	TPI-287IBA 01/2020
1	Lysine AcetyltransferasesIBA 01/2020
1	Amantadine (Aman)FDA LinkGeneric 01/2020
1	Nicardipine (Dagan)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 12/2018
1	DipeptidesIBA 05/2018
1	24-hydroxycholesterolIBA 01/2018
1	UbiquitinIBA 12/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2017
1	tideglusibIBA 01/2017
1	EkoIBA 01/2017
1	AntibodiesIBA 01/2017
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 07/2015
1	AD 5IBA 01/2015
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 11/2014
1	Unithiol (DMPS)IBA 03/2014
1	Peptides (Polypeptides)IBA 07/2010
1	bapineuzumabIBA 07/2010

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2007
1	Wearable Electronic Devices 01/2020
1	Activities of Daily Living (ADL) 01/2016
1	Speech Therapy (Therapy, Speech) 11/2014
1	Immunotherapy 07/2010